Zobrazeno 1 - 7
of 7
pro vyhledávání: '"O. R. Ødegaard"'
Publikováno v:
Journal of Fish Diseases. 18:623-626
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 55:133-137
We have evaluated an automated, simplified, turbidimetric method for the measurement of the C4b binding protein (C4bBP). A comparison with a manually performed electroimmunoassay in plasma samples referred for coagulation analysis (n = 80) revealed a
Publikováno v:
Journal of Fish Diseases. 16:425-435
Consumptive coagulopathy was induced within 4 h in Atlantic salmon, Salmo salar L., by injecting purified serine protease from Aeromonas salmonicida into the dorsal aorta. Pretreatment with a bolus intravascular injection of (human) antithrombin (AT)
Publikováno v:
Journal of Fish Diseases. 15:215-227
Intravascular injection of purified 70-kDa protease or GCAT-LPS from Aeromonas salmonicida, or both, invariably led to consumptive coagulopathy within 2h in Atlantic salmon, Salmo salar L. By entering the coagulation cascade at two different levels,
Publikováno v:
Journal of Fish Diseases. 14:401-406
Thrombosis of minute vessels is a common feature of acute furunculosis in Atlantic salmon. Crude extracellular products (F.CP) of Aeromans, salmonicida injected into the dorsal aorta of cannulated fish elicited an activation of the coagulations syste
Autor:
J. C. Gallagher, R. R. Recker, B. L. Riggs, A. Caniggia, R. Nuti, F Lore, A. Vattimo, H. A. Morris, B. E. C. Nordin, V Fräser, T. E Hartley, A. G. Need, M. Horowitz, J. P Huaux, J. P Devogelaer, J. P Brasseur, C. Nagant de Deuxchaisnes, T. Nakamura, K. Nakamura, A. Nagano, Y. Nishii, T. Kurokawa, A. Bridges, C. Walker, J. A. Falch, O. R. Ødegaard, A. M. Finnanger, M. J. McKenna, M. Kleerekoper, D. S. Rao, B. Ellis, A. M. Parfitt, B. Frame, G. Saggese, G. Cesaretti, S. Bertelloni, G. Federico, E. Bottone, T. L. Clemens, S. Silverberg, D. W Dempster, E. Shane, G. V Segre, S. Williams, R. Lindsay, J. P Bilizekian, B. Lalor, M. Davies, B H. Adams, T. B. Counihan, J. C. Stevenson, G. Abeyasekkera, P R. Allen, M. I. Whitehead, K. J. Tassie, P Lips, M. J. M. Jongen, F C. van Ginkel, J. C. Netelenbos, W J. E van der Vijgh, B. J. Riis, L. Hummer, K. Thomsen, L. Nilas, A. Gotfredsen, C. Christiansen, E. Palummeri, G. Cervellin, M. Pedrazzoni, D. Cucinotta, M. Passeri, C. Meossi, B. Lund, O. H. Sørensen, R. B. Andersen, L. Mosekilde, C. Egsmose, T. S. Lindholm, T. C. Lindholm, S. Erikson, M. Massimetti, J. Cipriani, B. E. Chatterton, T. A. Streuer, L. Tjellesen, P Rødbro, R. M. Francis, M. Peacock, C. J. Gibbs, S. A. Barkworth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebdd59b4d9285031709fd64dc7b77acf
https://doi.org/10.1515/9783112330005-021
https://doi.org/10.1515/9783112330005-021
Publikováno v:
XIth International Congress on Thrombosis and Haemostasis.
The activity levels of the “new” coagulation inhibitors, heparin cofactor II (HC II) and extrinsic pathway inhibitor (EPI),have been determined with chromogenic substrates assays, in patients with pneumonia (n=8), disseminated intravascular coagu